Cesar Castillo Alicea
Vascular Surgery · San Juan, PRNPI 1629475991
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.8%), speaking fees and education — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Johnson & Johnson at 42.9% of the total.
Across 76 payments — averaging $129.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$4K
- Medtronic$1K
- Penumbra, Inc.$808
- Silk Road Medical, Inc.$499
- W. L. Gore & Associates, Inc.$489
- Cook Medical LLC$396
- plus $2K from 20 others
What the payments were for
- Speaking & faculty fees$4,18542%
- Food & beverage$5,29954%
- Education$3714%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 4 | $4,233 |
| Medtronic(2 entities) | 17 | $1,198 |
| Penumbra, Inc. | 6 | $808 |
| Silk Road Medical, Inc. | 6 | $499 |
| W. L. Gore & Associates, Inc. | 8 | $489 |
| Cook Medical LLC | 5 | $396 |
| Shockwave Medical, Inc | 3 | $363 |
| Integra Lifesciences Corporation | 3 | $348 |
| Boston Scientific | 4 | $308 |
| Bolton Medical Inc | 2 | $261 |
| Endologix LLC | 2 | $185 |
| Cvrx, Inc. | 2 | $176 |
| Acera Surgical, Inc. | 1 | $150 |
| Lemaitre Vascular, Inc. | 1 | $118 |
| Merck | 1 | $94 |
| Smith+Nephew | 1 | $30 |
| Stryker | 1 | $28 |
| Philips North America LLC | 1 | $26 |
| Bard Peripheral Vascular, Inc. | 1 | $25 |
| Organogenesis Inc. | 1 | $24 |
| Inari Medical, Inc. | 1 | $24 |
| Distalmotion US | 1 | $18 |
| Intercept Pharmaceuticals, Inc. | 1 | $14 |
| Convatec Inc. | 1 | $14 |
| Mimedx Group, Inc. | 1 | $14 |
| Solventum Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$4,185
- INTEGRA$1,007
- Indigo System$567
- ENROUTE Transcarotid Stent$509
- ENROUTE Transcarotid Neuroprotection System$442
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$336
- INTEGRA DERMAL REGENERATION TEMPLATE$336
- PRIMATRIX$336
- ENDURANT IIS$271
- Grafts$153
- Restrata Wound Matrix$150
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$147
- Penumbra System$146
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$142
- Barostim Neo System$140
- Alto Abdominal Stent Graft System$134
- Zenith$126
- Endurant$125
- ARTEGRAFT VASCULAR GRAFT$118
- HawkOne$115
How this compares
$9,855 in reported general payments places this provider in the 80th percentile of 20 vascular surgery providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 22 | $14,839 |
| ClopidogrelClopidogrel Bisulfate | 39 | $356 |
| Atorvastatin Calcium | 20 | $191 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 11 | $59 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $4,233 | $14,83922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 20 vascular surgery providers in Puerto Rico.
Other vascular surgery in San Juan
- Fernando Joglar-IrizarrySan Juan$48K
- Ivan DominguezSan Juan$37K
- Francisco Aponte RiveraSan Juan$742
- Agustin Rodriguez GonzalezSan Juan$709
- Carlos Calimano GuardiolaSan Juan$526
- Leonardo ValentinManati$12K
- Gabriel Pereira TorrellasPonce$9K
- Jorge Martinez TrabalPonce$8K
- Rafael Santini DominguezPonce$8K
- Angel Menendez-AponteBayamon$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.